EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study

Soo-Kyung Cho, Jung-Yong Han, Yena Jeon, Seung-Hun You, Sun-Young Jung, Eun Jin Jang, Yoon-Kyoung Sung

Arthritis Research & Therapy · 2025

DOI: 10.1186/s13075-025-03482-2 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Arthritis Research & Therapy, 2025. Verfasst von Soo-Kyung Cho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, 04763, South Korea. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Neoplasms, Immunosuppressive Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: To investigate cancer incidence and the potential influence of immunosuppressive agents in Korean systemic lupus erythematosus (SLE) patients. METHODS: We conducted a retrospective analysis utilizing data from the Korea Healthcare Bigdata Linked Platform, which integrated the National Central Cancer Registry and National Health Insurance Service databases covering the period 2008-2017. Incidence rates (IRs) per 10,000 person-years (PYs) for site-specific cancers of SLE patients were calculated using ICD-O-3 codes. Multivariable logistic regression analysis was utilized to assess the association between immunosuppressive agents and cancer development in SLE patients. RESULTS: A total of 10,013 predominantly female (91%) Korean SLE patients with a mean age of 36.9 ± 15.2 years were included. During a follow-up of 62,268.5 PYs, 368 patients developed cancer. The IRs per 10,000 PYs for total, solid, and hematologic cancers were 59.07, 54.09, and 5.78, respectively. The most prevalent cancers (measured in IRs per 10,000 PYs) were thyroid (17.01, 95% CI 13.78-20.25), breast (8.67, 95% CI 6.36-10.98), stomach (4.49, 95% CI 2.83-6.16), colorectal (4.17, 95% CI 2.57-5.78), and cervical (3.85, 95% CI 2.31-5.39). Approximately half (50.8%) of SLE patients with cancer were diagnosed at the localized Surveillance, Epidemiology, and End Results (SEER) stage. No statistically significant association was found between immunosuppressive agents and cancer development (Odds Ratio 1.03, 95% CI 0.80-1.34). CONCLUSION: Our study shows that Korean SLE patients using immunosuppressive agents are not significantly more likely to develop cancer. Further research with extended observation is warranted to corroborate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicNeoplasmsImmunosuppressive AgentsHumansFemaleRetrospective StudiesIncidenceRepublic of KoreaMaleAdultMiddle AgedYoung AdultRegistriesAged

Stichwörter der Autor:innen

CancerImmunosuppressive agentsIncidence rateSystemic lupus erythematosus

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, 04763, South Korea.
  • Hanyang University Institute for Rheumatology Research, Seoul, South Korea.
  • Department of Statistics, Kyungpook National University, Daegu, South Korea.
  • College of Pharmacy, Chung-Ang University, Seoul, South Korea.
  • Department of Data Science, Andong National University, Andong, South Korea.
  • Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, 04763, South Korea. sungyk@hanyang.ac.kr.

Zitieren

APA

Cho, S. K., Han, J. Y., Jeon, Y., You, S. H., Jung, S. Y., Jang, E. J., & Sung, Y. K. (2025). Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-025-03482-2

Vancouver

Cho SK, Han JY, Jeon Y, You SH, Jung SY, Jang EJ, et al. Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study. Arthritis Research & Therapy. 2025. doi:10.1186/s13075-025-03482-2

BibTeX
@article{Cho2025,
  author = {Cho, Soo-Kyung and Han, Jung-Yong and Jeon, Yena and You, Seung-Hun and Jung, Sun-Young and Jang, Eun Jin and Sung, Yoon-Kyoung},
  title = {Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study},
  journal = {Arthritis Research & Therapy},
  year = {2025},
  doi = {10.1186/s13075-025-03482-2}
}
Kostenlos starten →